A Rapid in Vitro Test for Chloroquine-Resistant Plasmodium falciparum

Ilya Y. Gluzman Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by Ilya Y. Gluzman in
Current site
Google Scholar
PubMed
Close
,
Donald J. Krogstad Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by Donald J. Krogstad in
Current site
Google Scholar
PubMed
Close
,
Augustine U. Orjih Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by Augustine U. Orjih in
Current site
Google Scholar
PubMed
Close
,
Kano Nkangineme Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by Kano Nkangineme in
Current site
Google Scholar
PubMed
Close
,
Thomas E. Wellems Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by Thomas E. Wellems in
Current site
Google Scholar
PubMed
Close
,
J. Tyler Martin Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by J. Tyler Martin in
Current site
Google Scholar
PubMed
Close
, and
Paul H. Schlesinger Washington University, University of Port Harcourt, National Institutes of Health, St. Louis, Missouri, Nigeria

Search for other papers by Paul H. Schlesinger in
Current site
Google Scholar
PubMed
Close
Restricted access

We report a rapid (2–3 hr) in vitro test for chloroquine resistance in Plasmodium falciparum. The test is based on the inhibition of chloroquine efflux by verapamil; it is performed by diluting infected blood in culture medium and incubating the diluted blood for 60 min at 37°C with 50 nM 3H-chloroquine, with and without 10 µM verapamil. The test can be performed with the ring stage parasites in the blood of infected patients and in the presence of white cells, platelets and anticoagulants (heparin, EDTA, or citrate). Although the test can be performed in triplicate with 20 µl of blood and specimens may be kept in anticoagulants at 4°C for up to 24 hr, parasitemias <0.1% limit the sensitivity of the assay. Inhibition of chloroquine efflux by verapamil may permit the rapid identification of chloroquine resistant P. falciparum in blood specimens from infected patients.

Author Notes

Save